New Risk • Jun 06
New minor risk - Dividend sustainability The company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 0.6% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.2x net interest cover). Earnings have declined by 18% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (0.7% net profit margin). Market cap is less than US$100m (₹5.73b market cap, or US$60.2m). New Risk • May 29
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 0.7% Last year net profit margin: 3.9% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.2x net interest cover). Earnings have declined by 18% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (0.7% net profit margin). Market cap is less than US$100m (₹6.38b market cap, or US$66.6m). Reported Earnings • May 29
Full year 2026 earnings released: EPS: ₹0.25 (vs ₹1.97 in FY 2025) Full year 2026 results: EPS: ₹0.25 (down from ₹1.97 in FY 2025). Revenue: ₹12.6b (down 31% from FY 2025). Net income: ₹88.7m (down 87% from FY 2025). Profit margin: 0.7% (down from 3.9% in FY 2025). The decrease in margin was driven by lower revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 42 percentage points per year, which is a significant difference in performance. Announcement • May 19
Best Agrolife Limited to Report Q4, 2026 Results on May 27, 2026 Best Agrolife Limited announced that they will report Q4, 2026 results on May 27, 2026 Valuation Update With 7 Day Price Move • Apr 06
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹14.22, the stock trades at a trailing P/E ratio of 20.9x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 80% over the past three years. Recent Insider Transactions • Feb 18
Board Member recently bought ₹1.5m worth of stock On the 13th of February, Surendra Nallamalli bought around 80k shares on-market at roughly ₹18.68 per share. This transaction amounted to 21% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought ₹29m more in shares than they have sold in the last 12 months. Reported Earnings • Feb 07
Third quarter 2026 earnings released: ₹0.36 loss per share (vs ₹0.68 loss in 3Q 2025) Third quarter 2026 results: ₹0.36 loss per share (improved from ₹0.68 loss in 3Q 2025). Revenue: ₹2.04b (down 26% from 3Q 2025). Net loss: ₹127.4m (loss narrowed 47% from 3Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 37 percentage points per year, which is a significant difference in performance. Announcement • Jan 28
Best Agrolife Limited to Report Q3, 2026 Results on Feb 06, 2026 Best Agrolife Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Feb 06, 2026 New Risk • Jan 20
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.8x net interest cover). Share price has been highly volatile over the past 3 months (9.1% average weekly change). Minor Risks Profit margins are more than 30% lower than last year (0.9% net profit margin). Market cap is less than US$100m (₹8.33b market cap, or US$91.6m). Valuation Update With 7 Day Price Move • Jan 20
Investor sentiment deteriorates as stock falls 22% After last week's 22% share price decline to ₹23.45, the stock trades at a trailing P/E ratio of 65.1x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 72% over the past three years. New Risk • Nov 26
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.8x net interest cover). Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Profit margins are more than 30% lower than last year (0.9% net profit margin). Market cap is less than US$100m (₹8.54b market cap, or US$95.7m). Valuation Update With 7 Day Price Move • Nov 26
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₹362, the stock trades at a trailing P/E ratio of 66.7x. Average trailing P/E is 24x in the Chemicals industry in India. Total loss to shareholders of 77% over the past three years. New Risk • Nov 13
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 0.9% Last year net profit margin: 2.1% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.7x net interest cover). Minor Risks Profit margins are more than 30% lower than last year (0.9% net profit margin). Market cap is less than US$100m (₹7.15b market cap, or US$80.7m). Announcement • Nov 08
Best Agrolife Limited to Report Q2, 2026 Results on Nov 12, 2025 Best Agrolife Limited announced that they will report Q2, 2026 results at 12:15 PM, Indian Standard Time on Nov 12, 2025 Announcement • Oct 01
Best Agrolife Limited Announces Board Appointments Best Agrolife Limited at its 34th Annual General Meeting held on 30th September, 2025, approved the appointment of Mr. Surendra Sai Nallamalli (DIN: 08837064) as a Whole-Time Director. Appointment of Mr. Pramod Narayan Karlekar (DIN: 01776461) as a Non- Executive Director Non-Independent Director. Upcoming Dividend • Sep 19
Upcoming dividend of ₹3.00 per share Eligible shareholders must have bought the stock before 23 September 2025. Payment date: 30 October 2025. Payout ratio is a comfortable 10% and this is well supported by cash flows. Trailing yield: 0.8%. Lower than top quartile of Indian dividend payers (1.2%). In line with average of industry peers (0.7%). Declared Dividend • Sep 05
Dividend of ₹3.00 announced Dividend of ₹3.00 is the same as last year. Ex-date: 23rd September 2025 Payment date: 30th October 2025 Dividend yield will be 0.8%, which is about the same as the industry average. Sustainability & Growth Dividend is well covered by both earnings (10% earnings payout ratio) and cash flows (3% cash payout ratio). The dividend has increased by an average of 46% per year over the past 9 years and payments have been stable during that time. Earnings per share has grown by 31% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Announcement • Sep 03
Best Agrolife Limited, Annual General Meeting, Sep 30, 2025 Best Agrolife Limited, Annual General Meeting, Sep 30, 2025, at 12:30 Indian Standard Time. New Risk • Aug 28
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₹8.44b (US$96.3m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.3x net interest cover). Share price has been highly volatile over the past 3 months (8.3% average weekly change). Minor Risk Market cap is less than US$100m (₹8.44b market cap, or US$96.3m). Announcement • Aug 26
Best Agrolife Limited to Report Fiscal Year 2025 Results on Sep 03, 2025 Best Agrolife Limited announced that they will report fiscal year 2025 results on Sep 03, 2025 Valuation Update With 7 Day Price Move • Aug 14
Investor sentiment deteriorates as stock falls 25% After last week's 25% share price decline to ₹380, the stock trades at a trailing P/E ratio of 13.1x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 58% over the past three years. Reported Earnings • Aug 08
First quarter 2026 earnings released: EPS: ₹38.42 (vs ₹9.00 in 1Q 2025) First quarter 2026 results: EPS: ₹38.42. Revenue: ₹3.81b (down 27% from 1Q 2025). Net income: ₹199.2m (down 6.4% from 1Q 2025). Profit margin: 5.2% (up from 4.1% in 1Q 2025). The increase in margin was driven by lower expenses. New Risk • Aug 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.4x net interest cover). Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Profit margins are more than 30% lower than last year (3.9% net profit margin). Announcement • Aug 02
Best Agrolife Limited to Report Q1, 2026 Results on Aug 07, 2025 Best Agrolife Limited announced that they will report Q1, 2026 results at 12:15 PM, Indian Standard Time on Aug 07, 2025 Valuation Update With 7 Day Price Move • Jul 21
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to ₹474, the stock trades at a trailing P/E ratio of 16x. Average trailing P/E is 30x in the Chemicals industry in India. Total loss to shareholders of 50% over the past three years. Announcement • Jul 02
Best Agrolife Limited Announces Board and Committee Changes Best Agrolife Limited announced that Mr. Balavenkatarama Prasad Suryadevara has resigned from his position as Whole-Time Director due to health issues, effective July 2, 2025. Mr. Shuvendu Kumar Satpathy has resigned from his position as Non-Executive Director due to unforeseen family circumstances, effective July 2, 2025. Consequent to his resignation he ceased to be the Chairman of the Stakeholder’s Relationship committee and members of Audit committee, Nomination & Remuneration Committee, Risk Management committee and Corporate Social Responsibility Committee. The Board of Directors has approved the reconstitution of various committees, including the Audit Committee, Nomination & Remuneration Committee, Stakeholder Relationship Committee, Corporate Social Responsibility Committee, and Risk Management Committee. The committees and their members are as follows: Audit Committee - Mrs. Chetna (Chairman), Mr. Braj Kishore Prasad (Member), and Mr. Pramod Narayan Karlekar (Member); Nomination & Remuneration Committee - Mrs. Chetna (Chairman), Mr. Braj Kishore Prasad (Member), and Mr. Pramod Narayan Karlekar (Member); Stakeholder Relationship Committee - Mr. Pramod Narayan Karlekar (Chairman), Mr. Braj Kishore Prasad (Member), and Mrs. Chetna (Member); Corporate Social Responsibility Committee - Mr. Braj Kishore Prasad (Chairman), Mr. Pramod Narayan Karlekar (Member), and Mrs. Chetna (Member); and Risk Management Committee - Mr. Braj Kishore Prasad (Chairman), Mr. Pramod Narayan Karlekar (Member), and Mrs. Chetna (Member). Valuation Update With 7 Day Price Move • Jul 01
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹379, the stock trades at a trailing P/E ratio of 12.8x. Average trailing P/E is 29x in the Chemicals industry in India. Total loss to shareholders of 60% over the past three years. Reported Earnings • May 25
Full year 2025 earnings released: EPS: ₹29.56 (vs ₹44.95 in FY 2024) Full year 2025 results: EPS: ₹29.56 (down from ₹44.95 in FY 2024). Revenue: ₹18.2b (down 2.9% from FY 2024). Net income: ₹698.9m (down 34% from FY 2024). Profit margin: 3.8% (down from 5.7% in FY 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 26% per year, which means it has not declined as severely as earnings. Announcement • May 20
Best Agrolife Limited to Report Q4, 2025 Results on May 24, 2025 Best Agrolife Limited announced that they will report Q4, 2025 results at 3:30 PM, Indian Standard Time on May 24, 2025 Valuation Update With 7 Day Price Move • Apr 23
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹343, the stock trades at a trailing P/E ratio of 42.3x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 62% over the past three years. Valuation Update With 7 Day Price Move • Mar 10
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₹309, the stock trades at a trailing P/E ratio of 38x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 66% over the past three years. Recent Insider Transactions • Mar 05
MD & Director recently bought ₹10m worth of stock On the 3rd of March, Vimal Alawadhi bought around 40k shares on-market at roughly ₹260 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Vimal's only on-market trade for the last 12 months. Recent Insider Transactions • Feb 25
Head of International Business recently bought ₹5.9m worth of stock On the 21st of February, N. Sai bought around 21k shares on-market at roughly ₹284 per share. This transaction increased N.'s direct individual holding by 10x at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought ₹8.8m more in shares than they have sold in the last 12 months. Valuation Update With 7 Day Price Move • Feb 21
Investor sentiment deteriorates as stock falls 31% After last week's 31% share price decline to ₹285, the stock trades at a trailing P/E ratio of 35.1x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 69% over the past three years. New Risk • Feb 17
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.6x net interest cover). Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Profit margins are more than 30% lower than last year (1.2% net profit margin). Market cap is less than US$100m (₹7.85b market cap, or US$90.4m). Reported Earnings • Feb 15
Third quarter 2025 earnings released: ₹10.22 loss per share (vs ₹2.80 loss in 3Q 2024) Third quarter 2025 results: ₹10.22 loss per share (further deteriorated from ₹2.80 loss in 3Q 2024). Revenue: ₹2.74b (down 13% from 3Q 2024). Net loss: ₹241.6m (loss widened 265% from 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 26% per year whereas the company’s share price has fallen by 24% per year. Announcement • Feb 03
Best Agrolife Limited to Report Q3, 2025 Results on Feb 14, 2025 Best Agrolife Limited announced that they will report Q3, 2025 results on Feb 14, 2025 Valuation Update With 7 Day Price Move • Nov 11
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹626, the stock trades at a trailing P/E ratio of 40.2x. Average trailing P/E is 35x in the Chemicals industry in India. Total loss to shareholders of 48% over the past three years. Reported Earnings • Oct 19
Second quarter 2025 earnings released: EPS: ₹40.03 (vs ₹40.12 in 2Q 2024) Second quarter 2025 results: EPS: ₹40.03 (down from ₹40.12 in 2Q 2024). Revenue: ₹7.48b (down 7.8% from 2Q 2024). Net income: ₹946.6m (flat on 2Q 2024). Profit margin: 13% (up from 12% in 2Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 17% per year, which means it is performing significantly worse than earnings. Valuation Update With 7 Day Price Move • Oct 17
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹617, the stock trades at a trailing P/E ratio of 39.4x. Average trailing P/E is 36x in the Chemicals industry in India. Total loss to shareholders of 41% over the past three years. Announcement • Oct 15
Best Agrolife Limited to Report Q2, 2025 Results on Oct 18, 2024 Best Agrolife Limited announced that they will report Q2, 2025 results on Oct 18, 2024 Declared Dividend • Sep 06
Dividend of ₹3.00 announced Dividend of ₹3.00 is the same as last year. Ex-date: 23rd September 2024 Payment date: 30th October 2024 Dividend yield will be 0.4%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (7% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 53% per year over the past 8 years and payments have been stable during that time. Earnings per share has grown by 29% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Valuation Update With 7 Day Price Move • Aug 26
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹658, the stock trades at a trailing P/E ratio of 42x. Average trailing P/E is 35x in the Chemicals industry in India. Total loss to shareholders of 6.4% over the past three years. Reported Earnings • Aug 13
First quarter 2025 earnings released: EPS: ₹9.00 (vs ₹38.28 in 1Q 2024) First quarter 2025 results: EPS: ₹9.00 (down from ₹38.28 in 1Q 2024). Revenue: ₹5.22b (down 15% from 1Q 2024). Net income: ₹212.8m (down 77% from 1Q 2024). Profit margin: 4.1% (down from 15% in 1Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Announcement • Aug 06
Best Agrolife Limited to Report Q1, 2025 Results on Aug 12, 2024 Best Agrolife Limited announced that they will report Q1, 2025 results on Aug 12, 2024 Recent Insider Transactions • Jul 03
Chief Financial Officer recently bought ₹914k worth of stock On the 27th of June, Vikash Jain bought around 1k shares on-market at roughly ₹703 per share. This transaction increased Vikash's direct individual holding by 1x at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Vikash's only on-market trade for the last 12 months. Valuation Update With 7 Day Price Move • Jun 11
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₹602, the stock trades at a trailing P/E ratio of 13.4x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 105% over the past three years. Announcement • May 26
Best Agrolife Limited Recommends Final Dividend for the Financial Year 2023-24 Best Agrolife Limited announced that at its Board of Directors of the Company in its meeting held on May 24, 2024, recommended final dividend, subject to approval of shareholders of INR 3(30%) per equity share of INR 10 each for the financial year 2023-24. Reported Earnings • May 25
Full year 2024 earnings released: EPS: ₹44.94 (vs ₹81.26 in FY 2023) Full year 2024 results: EPS: ₹44.94 (down from ₹81.26 in FY 2023). Revenue: ₹18.8b (up 7.5% from FY 2023). Net income: ₹1.06b (down 45% from FY 2023). Profit margin: 5.7% (down from 11% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth. Announcement • May 18
Best Agrolife Limited to Report Q4, 2024 Results on May 24, 2024 Best Agrolife Limited announced that they will report Q4, 2024 results on May 24, 2024 Board Change • Apr 10
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Additional Independent Non-Executive Director Chetna Mann was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Jan 26
Best Agrolife Limited to Report Q3, 2024 Results on Feb 05, 2024 Best Agrolife Limited announced that they will report Q3, 2024 results on Feb 05, 2024 Announcement • Nov 02
Best Agrolife Limited to Report Q2, 2024 Results on Nov 08, 2023 Best Agrolife Limited announced that they will report Q2, 2024 results on Nov 08, 2023 Announcement • Sep 03
Best Agrolife Limited, Annual General Meeting, Sep 27, 2023 Best Agrolife Limited, Annual General Meeting, Sep 27, 2023, at 12:30 Indian Standard Time. Announcement • Aug 29
Best Agrolife Limited Announces the Launch of New Proprietary Product Best Agrolife Limited announced the launch of its new product in the name and style of,TRICOLOR". TRICOLOR the latest innovation from Best Agrolife Limited, comprises Trifloxystrobin 10t% + Difenoconazole 12.5 % + Sulphur 3% SC. This potent blend acts as a broad-spectrum fungicide with prophylactic, curative, and eradicative actions' The addition of Sulphur serves as a catalyst, enhancing the efficacy of the active ingredients threefold. This unique composition provides outstanding control against various crop diseases such as Sheath blight, Powdery Mildew, Scab, and Alternaria across diverse crops including rice, tomato, Grapes, Chilli, Wheat, Mango, and Apple. Reported Earnings • Aug 01
First quarter 2024 earnings released: EPS: ₹38.28 (vs ₹16.97 in 1Q 2023) First quarter 2024 results: EPS: ₹38.28 (up from ₹16.97 in 1Q 2023). Revenue: ₹6.17b (up 33% from 1Q 2023). Net income: ₹905.0m (up 125% from 1Q 2023). Profit margin: 15% (up from 8.7% in 1Q 2023). The increase in margin was driven by higher revenue. Announcement • Jul 25
Best Agrolife Limited to Report Q1, 2024 Results on Jul 31, 2023 Best Agrolife Limited announced that they will report Q1, 2024 results on Jul 31, 2023 Announcement • Jun 10
Best Agrolife Limited Receives the Registrations for the Indigenous Manufacturing of the Product Trifloxystrobin 10% + Difenoconazole 12.5% + Sulphur 3% Sc Best Agrolife Limited has received the registrations for the indigenous manufacturing of the product Trifloxystrobin 10% + Difenoconazole 12.5% + Sulphur 3% Sc under section 9 (3) FIM from Central Insecticides Board & Registration Committee (CIBRC). With this Best Agrolife Limited (BAL) will become the first Indian agrochemical company to manufacture the combination product of Trifloxystrobin 10% + Difenoconazole 12.5% + Sulphur 3% Sc in India with brand name Tricolor. BAL is all set to launch this product in July with the brand name Tricolor and it will be the companypatented product. The company is launching Propaquizafop and Amytrn with the brand name Propique and Amito respectively in the first quarter of FY24. All these products will help in maintaining the goal of 30% growth and 20% EBITDA margin in the current financial year. Reported Earnings • May 31
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: EPS: ₹81.26 (up from ₹45.98 in FY 2022). Revenue: ₹17.5b (up 44% from FY 2022). Net income: ₹1.92b (up 83% from FY 2022). Profit margin: 11% (up from 8.7% in FY 2022). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 4.7%. Earnings per share (EPS) also missed analyst estimates by 18%. Announcement • May 20
Best Agrolife Limited to Report Q4, 2023 Results on May 29, 2023 Best Agrolife Limited announced that they will report Q4, 2023 results on May 29, 2023 Reported Earnings • Jan 26
Third quarter 2023 earnings: EPS and revenues miss analyst expectations Third quarter 2023 results: EPS: ₹12.95 (up from ₹6.55 in 3Q 2022). Revenue: ₹3.28b (up 41% from 3Q 2022). Net income: ₹306.2m (up 98% from 3Q 2022). Profit margin: 9.3% (up from 6.7% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 40%. Earnings per share (EPS) also missed analyst estimates by 38%. Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Announcement • Jan 20
Best Agrolife Limited to Report Q3, 2023 Results on Jan 25, 2023 Best Agrolife Limited announced that they will report Q3, 2023 results on Jan 25, 2023 Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Additional Independent Non-Executive Director Chetna Mann was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 23
Second quarter 2023 earnings released: EPS: ₹54.90 (vs ₹11.43 in 2Q 2022) Second quarter 2023 results: EPS: ₹54.90 (up from ₹11.43 in 2Q 2022). Revenue: ₹7.01b (up 116% from 2Q 2022). Net income: ₹1.30b (up 415% from 2Q 2022). Profit margin: 19% (up from 7.8% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Valuation Update With 7 Day Price Move • Oct 21
Investor sentiment improved over the past week After last week's 16% share price gain to ₹1,513, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 45% over the past year. Upcoming Dividend • Sep 13
Upcoming dividend of ₹2.00 per share Eligible shareholders must have bought the stock before 20 September 2022. Payment date: 28 October 2022. Payout ratio is a comfortable 3.9% but the company is not cash flow positive. Trailing yield: 0.2%. Lower than top quartile of Indian dividend payers (1.5%). Lower than average of industry peers (0.7%). Valuation Update With 7 Day Price Move • Aug 30
Investor sentiment improved over the past week After last week's 21% share price gain to ₹1,107, the stock trades at a trailing P/E ratio of 18.3x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 49% over the past year. Reported Earnings • Aug 06
First quarter 2023 earnings released: EPS: ₹16.97 (vs ₹11.77 in 1Q 2022) First quarter 2023 results: EPS: ₹16.97 (up from ₹11.77 in 1Q 2022). Revenue: ₹4.64b (up 35% from 1Q 2022). Net income: ₹401.3m (up 55% from 1Q 2022). Profit margin: 8.6% (up from 7.5% in 1Q 2022). The increase in margin was driven by higher revenue. Valuation Update With 7 Day Price Move • Jul 07
Investor sentiment improved over the past week After last week's 15% share price gain to ₹946, the stock trades at a trailing P/E ratio of 21.6x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 136% over the past year. Reported Earnings • May 24
Full year 2022 earnings released: EPS: ₹45.98 (vs ₹16.83 in FY 2021) Full year 2022 results: EPS: ₹45.98 (up from ₹16.83 in FY 2021). Revenue: ₹12.1b (up 34% from FY 2021). Net income: ₹1.05b (up 183% from FY 2021). Profit margin: 8.6% (up from 4.1% in FY 2021). The increase in margin was driven by higher revenue. Board Change • Apr 27
Less than half of directors are independent There are 6 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). Independent Chairman Braj Prasad is the most experienced director on the board, commencing their role in 2019. Additional Independent Non-Executive Director Chetna Mann was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Recent Insider Transactions • Apr 09
Insider recently sold ₹2.8m worth of stock On the 5th of April, Geeta Garg sold around 3k shares on-market at roughly ₹1,122 per share. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Valuation Update With 7 Day Price Move • Apr 04
Investor sentiment improved over the past week After last week's 21% share price gain to ₹1,047, the stock trades at a trailing P/E ratio of 26.4x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 145% over the past year. Reported Earnings • Jan 26
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: ₹6.55 (up from ₹1.24 in 3Q 2021). Revenue: ₹2.32b (up 309% from 3Q 2021). Net income: ₹154.8m (up 465% from 3Q 2021). Profit margin: 6.7% (up from 4.8% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Reported Earnings • Oct 27
Second quarter 2022 earnings released: EPS ₹11.43 (vs ₹0.83 in 2Q 2021) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹3.25b (up 17% from 2Q 2021). Net income: ₹251.9m (up ₹233.7m from 2Q 2021). Profit margin: 7.8% (up from 0.7% in 2Q 2021). The increase in margin was driven by higher revenue. Valuation Update With 7 Day Price Move • Oct 26
Investor sentiment improved over the past week After last week's 15% share price gain to ₹1,175, the stock trades at a trailing P/E ratio of 56x. Average trailing P/E is 18x in the Chemicals industry in India. Valuation Update With 7 Day Price Move • Oct 07
Investor sentiment improved over the past week After last week's 25% share price gain to ₹979, the stock trades at a trailing P/E ratio of 38.7x. Average trailing P/E is 20x in the Chemicals industry in India. 
